- £3.05bn
- £1.23bn
- £5.03bn
- 87
- 73
- 91
- 97
R2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,964 | 3,585 | 395 | 1,232 | 5,034 |
Cost of Revenue | |||||
Gross Profit | 593 | 722 | -101 | 10.4 | 893 |
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,758 | 3,399 | 732 | 1,556 | 4,640 |
Operating Profit | 207 | 185 | -336 | -324 | 394 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 167 | 148 | -370 | -389 | 371 |
Provision for Income Taxes | |||||
Net Income After Taxes | 137 | 112 | -300 | -315 | 291 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 140 | 116 | -271 | -315 | 291 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 140 | 116 | -271 | -315 | 305 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.903 | 0.606 | -1.67 | -1.47 | 1.26 |
Dividends per Share |